Baldwidx wrote:
"Jon seemed to suggest to me that they are not necessarily talking to Big Pharma or something along those lines, which made me slightly uneasy. I don't want to see another Acadia style deal with a small Pharma."
He did say that. My impression/gut feel was that he was referring to someone like a Blackstone.
Ann: Phase 2 trial shows significant improvements in Angelman, page-59
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.11 |
Change
0.410(3.23%) |
Mkt cap ! $1.675B | |||
| Open | High | Low | Value | Volume |
| $13.02 | $13.12 | $12.89 | $8.524M | 654.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5580 | $13.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.11 | 11667 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |